Prenatal Cannabis Exposure and Executive Function and Aggressive Behavior at Age 5 Years.  Keim SA, Fried P, Yeates KO, et al.  JAMA Pediatr. Published online October 28, 2024. doi:10.1001/jamapediatrics.2024.4352 Abstract https...

ASAM. Engagement and Retention of Nonabstinent Patients in Substance Use Treatment - Clinical Consideration for Addiction Treatment Providers Initiation, engagement, and retention in treatment are critical factors that impact long-term outcomes f...

Addiction Treatment 101 - Learn the basics in 40 minutes!  This course provides an introduction to substance use disorder treatment, including the different types of medications used to treat opioid use disorder, and how these medications wo...

6th European Harm Reduction Conference – EHRC2024! Warschau – 2.-4.12.2024 Putting People First – Empowering communities and driving innovation https://www.harmreductionconference.eu/

The association between glucose-dependent insulinotropic polypeptide and/or glucagon-like peptide-1 receptor agonist prescriptions and substance-related outcomes in patients with opioid and alcohol use disorders: A real-world data analysis.  ...

Semaglutid und andere GLP-1-Agonisten könnten bei Drogensucht helfen Chicago – US-Patienten mit einer Opiat- oder Alkoholabhängigkeit, denen zur Behandlung eines gleichzeitig bestehenden Typ 2-Diabetes oder einer Adipositas Semaglutid oder ein an...